Evidence map›Paper›PMID 26728034›Full record

ArticleParasites & vectors2016

LmABCB3, an atypical mitochondrial ABC transporter essential for Leishmania major virulence, acts in heme and cytosolic iron/sulfur clusters biogenesis.

Marta Martínez-García, Jenny Campos-Salinas, María Cabello-Donayre, Estela Pineda-Molina, Francisco J Gálvez, Lina M Orrego, María P Sánchez-Cañete, Sophie Malagarie-Cazenave, David M Koeller, José M Pérez-Victoria

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Applied and environmental microbiology · 2019
    Article
  13. Emerging therapeutic targets for treatment of leishmaniasis.Expert opinion on therapeutic targets · 2018
    Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Marta Martínez-GarcíaInstituto de Parasitología y Biomedicina "López-Neyra" (IPBLN), CSIC, PTS Granada, Granada, Spain. martamg@ipb.csic.es.
Jenny Campos-SalinasInstituto de Parasitología y Biomedicina "López-Neyra" (IPBLN), CSIC, PTS Granada, Granada, Spain. jennycampos@ipb.csic.es.
María Cabello-DonayreInstituto de Parasitología y Biomedicina "López-Neyra" (IPBLN), CSIC, PTS Granada, Granada, Spain. mariacabello@ipb.csic.es.
Estela Pineda-MolinaInstituto de Parasitología y Biomedicina "López-Neyra" (IPBLN), CSIC, PTS Granada, Granada, Spain. estelap.pineda@gmail.com.
Francisco J GálvezInstituto de Parasitología y Biomedicina "López-Neyra" (IPBLN), CSIC, PTS Granada, Granada, Spain. frangalv@hotmail.es.
Lina M OrregoInstituto de Parasitología y Biomedicina "López-Neyra" (IPBLN), CSIC, PTS Granada, Granada, Spain. linaorrego256@ipb.csic.es.
María P Sánchez-CañeteInstituto de Parasitología y Biomedicina "López-Neyra" (IPBLN), CSIC, PTS Granada, Granada, Spain. sophie.malagarie@gmail.com.
Sophie Malagarie-CazenaveInstituto de Parasitología y Biomedicina "López-Neyra" (IPBLN), CSIC, PTS Granada, Granada, Spain.
David M KoellerDepartment of Molecular & Medical Genetics, Oregon Health & Science University, Portland, OR, USA. koellerd@ohsu.edu.
José M Pérez-VictoriaInstituto de Parasitología y Biomedicina "López-Neyra" (IPBLN), CSIC, PTS Granada, Granada, Spain. josepv@ipb.csic.es.
Instituto de Parasitología y Biomedicina "López - Neyra" · ESOregon Health & Science University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMitochondria play essential biological functions including the synthesis and trafficking of porphyrins and iron/sulfur clusters (ISC), processes that in mammals involve the mitochondrial ATP-Binding Cassette (ABC) transporters ABCB6 and ABCB7, respectively. The mitochondrion of pathogenic protozoan parasites such as Leishmania is a promising goal for new therapeutic approaches. Leishmania infects human macrophages producing the neglected tropical disease known as leishmaniasis. Like most trypanosomatid parasites, Leishmania is auxotrophous for heme and must acquire porphyrins from the host.

methodsLmABCB3, a new Leishmania major protein with significant sequence similarity to human ABCB6/ABCB7, was identified and characterized using bioinformatic tools. Fluorescent microscopy was used to determine its cellular localization, and its level of expression was modulated by molecular genetic techniques. Intracellular in vitro assays were used to demonstrate its role in amastigotes replication, and an in vivo mouse model was used to analyze its role in virulence. Functional characterization of LmABCB3 was carried out in Leishmania promastigotes and Saccharomyces cerevisiae. Structural analysis of LmABCB3 was performed using molecular modeling software.

resultsLmABCB3 is an atypical ABC half-transporter that has a unique N-terminal extension not found in any other known ABC protein. This extension is required to target LmABCB3 to the mitochondrion and includes a potential metal-binding domain. We have shown that LmABCB3 interacts with porphyrins and is required for the mitochondrial synthesis of heme from a host precursor. We also present data supporting a role for LmABCB3 in the biogenesis of cytosolic ISC, essential cofactors for cell viability in all three kingdoms of life. LmABCB3 fully complemented the severe growth defect shown in yeast lacking ATM1, an orthologue of human ABCB7 involved in exporting from the mitochondria a gluthatione-containing compound required for the generation of cytosolic ISC. Indeed, docking analyzes performed with a LmABCB3 structural model using trypanothione, the main thiol in this parasite, as a ligand showed how both, LmABCB3 and yeast ATM1, contain a similar thiol-binding pocket. Additionally, we show solid evidence suggesting that LmABCB3 is an essential gene as dominant negative inhibition of LmABCB3 is lethal for the parasite. Moreover, the abrogation of only one allele of the gene did not impede promastigote growth in axenic culture but prevented the replication of intracellular amastigotes and the virulence of the parasites in a mouse model of cutaneous leishmaniasis.

conclusionsAltogether our results present the previously undescribed LmABCB3 as an unusual mitochondrial ABC transporter essential for Leishmania survival through its role in the generation of heme and cytosolic ISC. Hence, LmABCB3 could represent a novel target to combat leishmaniasis.

Indexed as

AnimalsATP-Binding Cassette TransportersHemeHumansIronLeishmania majorLeishmaniasisMaleMiceMice, Inbred C57BLMitochondriaModels, MolecularProtein TransportSulfurVirulenceATP-Binding Cassette TransportersHemeIronSulfur

Identifiers

PMID26728034
PMCPMC4700571
OpenAlexW2231231695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.